EUVIMEDEUVIMED entdecken
Open Access

Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US

Pieter A Cohen, Bharathi Avula, Yan-Hong Wang, Kumar Katragunta, Ikhlas Khan

JAMA · 25.04.2023 · 329 (16) · 1401

DOI: 10.1001/jama.2023.2296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 25.04.2023. Verfasst von Pieter A Cohen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Health Alliance, Somerville, Massachusetts. Hauptthemen laut MEDLINE: Cannabidiol, Cannabis, Melatonin. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study assesses the actual measured quantities of melatonin and cannabidiol (CBD) in products marketed and sold in the US as melatonin gummies compared with the quantities declared on their labels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolCannabisMelatoninAdministration, OralUnited StatesDosage Forms

Substanzen

CannabidiolMelatoninDosage Forms

Autor:innen und Institutionen

  • Cambridge Health Alliance, Somerville, Massachusetts.
  • University of Mississippi, University.

Zitieren

APA

Cohen, P. A., Avula, B., Wang, Y. H., Katragunta, K., & Khan, I. (2023). Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA, 329(16), 1401. https://doi.org/10.1001/jama.2023.2296

Vancouver

Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. 2023;329(16):1401. doi:10.1001/jama.2023.2296

BibTeX
@article{Cohen2023,
  author = {Cohen, Pieter A and Avula, Bharathi and Wang, Yan-Hong and Katragunta, Kumar and Khan, Ikhlas},
  title = {Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US},
  journal = {JAMA},
  year = {2023},
  volume = {329},
  number = {16},
  pages = {1401},
  doi = {10.1001/jama.2023.2296}
}
Kostenlos starten →